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OBJECTIVES This study was designed to assess the safety, efficacy, medium-term outcome, and compli-
cations of patent ductus arteriosus (PDA) stenting in duct-dependent pulmonary circulation.
BACKGROUND Patent ductus arteriosus stenting has been proposed as an alternative to surgical shunt on
account of postoperative morbidity and complications of surgical shunting.
METHODS Between April 2000 and February 2003, 69 patients with duct-dependent pulmonary
circulation underwent cardiac catheterization with the intent of PDA stenting as first
palliative procedure. Patients with critical pulmonary stenosis and pulmonary atresia with
intact ventricular septum post-radiofrequency valvotomy who had PDA stenting were
excluded. Thirteen more patients were excluded because of branch pulmonary artery (PA)
stenosis. The follow-up was by clinical examination, echocardiography, and repeat cardiac
catheterization at six to nine months following the procedure.
RESULTS Patent ductus arteriosus stenting was successful in 51 patients (91.1%) and failed in 5 patients
(8.9%). The mean narrowest PDA diameter was 1.9  0.6 mm. The mean procedure and
fluoroscopy time were 95.7 min and 29.4 min, respectively. In one patient the stent dislodged
and migrated to the left femoral artery and another patient developed transient intravascular
hemolysis. There was no procedure-related mortality. Three patients (5.9%) died one day to
two months after the procedure. At follow-up (3.2 months to 2.4 years), 8 patients developed
significant stent stenosis requiring reintervention. Seven patients developed worsening of
preexisting branch PA stenosis. The freedom from reintervention was 89% and 55% at 6
months and 1 year, respectively.
CONCLUSIONS Patent ductus arteriosus stenting is an attractive alternative to surgical shunt in a majority of
patients with duct-dependent circulation. An absolute contraindication to this technique is
the presence of branch pulmonary stenosis. (J Am Coll Cardiol 2004;44:438–45) © 2004
by the American College of Cardiology Foundatione
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tespite advances in surgical repair techniques of congenital
eart diseases and a trend towards early primary repair, the
urgical aortopulmonary shunt remains an important first-
tage palliation in duct-dependent cyanotic congenital heart
isease. However, in neonates and small infants a surgically
reated aortopulmonary shunt is not without significant
orbidity. Pleural effusion, diaphragmatic paralysis, cardiac
ailure due to excessive pulmonary blood flow, and distor-
ion of branch pulmonary arteries are known complications
hat may compromise the feasibility or outcome of repair
1,2). Stenting of the patent ductus arteriosus (PDA) was
hought to be a novel approach as an alternative first-stage
alliation, but results of earlier reports have been discour-
ging (3,4). However, with improvement in coronary stent
esign and delivery systems, it is perhaps reasonable to
eexamine the role of PDA stenting as an alternative to
urgical aortopulmonary shunts.
The objective of stenting the PDA in our institution was
o avoid or delay performing surgical shunts in neonates and
oung infants, in view of the higher postoperative morbidity
n this group.
From the National Heart Institute, Kuala Lumpur, Malaysia.
Manuscript received December 3, 2003; revised manuscript received March 19,v004, accepted March 30, 2004.This retrospective study was to assess the safety and
fficacy of PDA stenting in cyanotic congenital heart disease
ith duct-dependant pulmonary circulation, as well as to
valuate the procedure’s short- and medium-term outcome
nd complications.
ETHODS
etween April 2000 and February 2003, 69 patients pre-
enting for the first time with duct-dependent congenital
eart disease underwent cardiac catheterization and angiog-
aphy under general anesthesia with the intent of stenting
he PDA as first-stage palliation. The majority of these
atients presented to us between one and three months of
ge. Excluded from the study were 12 patients with pulmo-
ary atresia with intact ventricular septum (PAIVS) and 6
atients with critical pulmonary stenosis (PS) in whom
DA stenting was part of right ventricle (RV) decompres-
ion procedure by radiofrequency valvotomy and balloon
ilatation, or when the stenting was performed as additional
rocedure due to persistent severe cyanosis (SaO2 70%).
The detailed diagnoses were first established by two-
imensional and Doppler echocardiography, categorizing
he patients as having either single-ventricle or two-
entricle physiology. Prostaglandin E1 infusion was stopped
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emained prostaglandin-E1-dependent, where it was dis-
ontinued at the commencement of the procedure.
Aortic arch angiography, mainly in anteroposterior, lat-
ral, and four-chamber views, was performed to evaluate the
DA morphology and the state of the pulmonary arteries.
he PDA origin from the descending aorta was noted, as
ell as its tortuosity and shape. The diameter at the PDA’s
arrowest point (usually its insertion into the pulmonary
rtery) as well as its length were measured. The presence of
tenosis of the branch pulmonary artery at its takeoff or at
he site of PDA insertion (pulmonary coarctation, Fig. 1)
as also noted. Later in the study, as PDA stenting
ppeared to have worsened preexisting branch PA stenosis,
atients with such abnormality (n 13) were excluded from
he study. Hemodynamic parameters such as arterial blood
ressure and aortic oxygen saturation were also measured
re- and post-stent implantation.
Patent ductus arteriosus stenting was performed retro-
radely in most patients via the femoral artery using a 4F
ong-sheath (Cooks Inc., Bloomington, Indiana). As most
DAs had their origin from the underside of the aortic arch,
4F pigtail catheter with its loop cut to give an “inverted J”
as used to engage the PDA ampulla. Patent ductus
rteriosus that had a more normal orientation (arising from
he descending aorta) or arose from the subclavian artery
Abbreviations and Acronyms
BT  Blalock-Taussig
LPA  left pulmonary artery
PA  pulmonary artery
PAIVS  pulmonary atresia with intact ventricular
septum
PDA  patent ductus arteriosus
PS  pulmonary stenosis
RF  radiofrequency
RPA  right pulmonary artery
RV  right ventricle
TOF  tetralogy of Fallot
VSD  ventricular septal defectFigure 1. Pulmonary coarctation. (a) Left pulmonary artery sere easily engaged for guide wire anchoring with the 4F
udkins right coronary catheter. A 0.014 Choice PT
oronary guide wire (Boston Scientific Scimed Inc., Maple
rove, Minnesota), which has a straight floppy tip but a
tiffer body, was navigated across the PDA and anchored in
distal pulmonary artery branch or looped in the main
ulmonary artery. Coronary stents were then implanted. In
ost ductus, the stent was implanted so that 2 to 3 mm of
he stent protruded into the main pulmonary artery and the
hole length of the ductus was covered up to the ductal-
ortic junction. The length of the stent chosen was 1 to 2
m longer than the ductal length between the aortic and
ulmonary end, with the guide wire across (as the guide wire
ends to straighten a tortuous duct). Stents with a diameter
f 3.5 mm were implanted in those weighing 3 kg, 4 mm
tents in those weighing 3 to 5 kg, and 4.5 mm in those
eighing 5 kg and above. The stent types are summarized in
able 1.
In a small number of patients with tetralogy of Fallot
TOF)–pulmonary atresia where the PDA had a very
roximal origin, stent implantation was performed antero-
radely where a 6F Judkins Right or Left guiding catheter
Cordis Corporation, Miami, Florida) was passed from the
enous side, across the ventricular septal defect, and into the
scending aorta.
Early in the series, only the distal half to two-thirds of the
uct was stented in those patients with long tubular ductus
hat arose from the subclavian artery.
All patients were ventilated for at least 6 h and given
eparin infusion at 25 units/kg/h for 48 h, followed by oral
spirin 5 mg/kg/day. Patients in whom PDA stenting was
ot attempted or unsuccessful were referred for modified
lalock-Taussig (BT) shunt. The follow-up was by clinical
xamination, echocardiography, and repeat cardiac catheter-
zation at six to nine months (earlier if clinically indicated)
ost stent implantation
tatistical analysis. The SPSS statistical program for
indows, version 11.5 (SPSS Inc., Chicago, Illinois) was
sed to perform data analysis. Data was expressed as mean
SD, median (range), and frequency (percentage). Thetenosis; (b) bilateral branch pulmonary artery stenosis.
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PDA Stenting in Duct-Dependent Cardiac Lesions July 21, 2004:438–45ifference in parameters before and after PDA stenting was
xamined using Wilcoxon signed-rank test. Probability of
reedom from reintervention was determined by the
aplan-Meier method. Reintervention was defined as either
atheter-related intervention (balloon dilatation of stent,
estenting) or BT shunt surgery. A p value of 0.05 was
onsidered to be statistically significant.
ESULTS
tenting of the PDA was attempted in 56 patients. The
edian age at the time of the procedure was 2.3 months
range 7 days to 2.8 years) and median weight was 3.9 kg
range 2.1 to 10.4 kg). Thirty percent of the patients were
eonates. Two patients were 2.5 kg and eight patients
ere above the age of 1 year. Almost all of these older
atients had TOF-pulmonary atresia with increasing cya-
osis despite a previous BT shunt, and in two patients the
ulmonary arteries were disconnected.
The patients were categorized as either having single-
entricle physiology eventually destined for the Fontan track
r two-ventricle physiology. The detailed diagnoses were as
er Figure 2. In patients with single-ventricle physiology,
AIVS with hypoplastic RV and tricuspid atresia made up
he largest number (64%), whereas in those with two-
entricle physiology, TOF with pulmonary atresia formed
he great majority (72%).
In 45 patients (88%), the PDA arose from underneath
he arch proximal to the origin of the most distal branch of
he arch. Most of these ductus formed a U-shaped curve
Table 1. Types of Stents Used
Stent Manufacturers
Jomed Jostent Flex Supreme System/Flex Master (JO
Germany)
Express (Boston Scientific Scimed, Inc., Maple Grov
Cordis J & J Bx Sonic/Bx Velocity (Cordis Europa N
Medtronic AVE S670 (Medtronic Inc., Minneapolis
Others
Total
igure 2. Diagnoses of patients who underwent successful stent implantation.
cTGA  congenital corrected transposition of great arteries; DILV 
ouble-inlet left ventricle; PA  pulmonary atresia; PAIVS  pulmonary
tresia with intact ventricular septum; PS  pulmonary stenosis; TA 
ricuspid atresia; TS  tricuspid stenosis; TGA  transposition of greatprteries; TOF  tetralogy of Fallot; VSD  ventricular septal defect.efore inserting into the pulmonary artery, and in five
atients, they took a tortuous course with multiple loops. In
our patients the ductus arose normally from the descending
orta and had a straight tubular course and in two patients
he ductus arose from the subclavian artery, giving the
ppearance of a modified BT shunt (Fig. 3).
In five patients (8.9%), PDA stenting was not successful
ecause of very proximal origin of the PDA from the aortic
rch, or extreme tortuosity with multiple sharp bends, such
hat stable anchoring of the coronary guide wire in a distal
ulmonary artery branch was not possible.
Of the 51 patients in whom PDA stenting was successful,
n 43 patients (84.3%) the procedure was done retrogradely
ia the femoral artery, and in the remaining 8 (15.7%) this
as done anterogradely (Fig. 4).
The mean PDA diameter at its narrowest part was 1.9 
.6 mm (range 0.6 to 2.9 mm) and mean length was 13.5 
.6 mm (range 4.8 to 24 mm). The great majority of stents
mplanted were of 4.0 mm and 4.5 mm diameter (94%).
he mean stent length was 15.7  3.1 mm (range 8 to 24
m). In one patient, two stents were implanted in tandem
o adequately cover the PDA length. The mean procedure
ime was 95.7  40.5 min (range 38 to 190 min) and mean
uoroscopy time was 29.4  18.5 min (range 7.2 to 76
in). The aortic oxygen saturation increased from a mean of
0.1  14.2% to 90.5  7.3% (p  0.0001) and the PDA
iameter increased from a mean of 1.9  0.6 mm to 4.2 
.7 mm (p  0.0001) immediately following the procedure.
he mean duration of ventilation post procedure was 1.7
ays and the mean hospital stay was 5 days (range 2 to 41
ays).
ortality and complications. There was no procedure-
elated mortality. In one patient the stent was dislodged
rom the balloon catheter and migrated to the left femoral
rtery. The stent was removed through a minor surgical
rocedure. Transient complete heart block, due presumably
o the stiff catheter pressing on the atrioventricular node,
ccurred in one patient. None of the patients lost their
emoral pulses.
A patient with mitral atresia and single ventricle devel-
ped severe cardiac failure and excessive pulmonary blood
ow. The patient died on the following day post-stenting. A
atient with trisomy-21 developed transient intravascular
emolysis due to mid-segment PDA that was resistant to
xpansion at maximum pressure, giving an hourglass ap-
n %
GmbH, Rangendingen, 24 47.1
innesota) 11 21.6
Roden, The Netherlands) 9 17.6
nesota) 3 5.9
4 7.8
51 100MED
e, M
.V.,
, Minearance to the expanded stent. She subsequently developed
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July 21, 2004:438–45 PDA Stenting in Duct-Dependent Cardiac Lesionsethicillin Resistant Staphylococcus Epidermidis septice-
ia and died at day 30. One patient with single-ventricle
ied in another hospital two months after discharge; the
ause appeared unrelated to the procedure.
ollow-up. The mean duration of follow-up was 9.6
onths (range 3.2 months to 2.4 years). The mean oxygen
aturation at last follow-up was 79.2 5.2%. One patient in
hom the PDA stent was completely blocked at three
eeks postprocedure received a modified BT shunt.
Twenty-five of the surviving patients underwent repeat
ardiac catheterization at 6 to 12 months post-stent implan-
ation. In eight patients, the PDA flow became inadequate
oxygen saturation 70%) within six months post-stent
igure 3. Morphology of arterial duct. (a) Ductus arising normally from de
eneath the aortic arch; (c) ductus arising from right subclavian artery.
igure 4. Transcatheter approaches of stent implantation. (a and b) pre-
uiding Judkin’s Right catheter was passed through ventricular septal defeistal pulmonary artery; (c) normal ductus morphology in tricuspid atresia; (d)mplantation because of intimal proliferation (n  6) and
onstriction of unstented segment of the PDA (n  2) (Fig.
). Two of these patients were destined for a single-ventricle
epair (PAIVS, n  1; tricuspid atresia with pulmonary
tresia, n  1) and the remaining six patients were those
ith TOF–PA (n 2), congenitally corrected transposition
f the great arteries with pulmonary atresia (n  3), and
ransposition of the great arteries with ventricular septal
efect and pulmonary atresia (n  1). These patients were
anaged by constructing a modified BT shunt (n  3),
lacement of additional stents (n  2), and balloon dilation
f stents (n  3).
In seven patients preexisting branch PA stenosis (six in
ing aorta and has a straight tubular course; (b) “vertical duct” arising from
post-stent implantation in tetralogy of Fallot-pulmonary atresia. A 6-F
d anterogradely into ascending aorta with guide wire securely anchored inscendand
ct anpost-stent implantation by retrograde transarterial approach.
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PDA Stenting in Duct-Dependent Cardiac Lesions July 21, 2004:438–45eft PA, one in right PA) became more severe and five of the
atients were referred for surgical shunt on the affected side
Fig. 6).
Freedom from reintervention for the 51 patients was 89%
nd 55% at six months and one year, respectively (Fig. 7).
hose patients less than three months of age had longer
uration of ventilation and hospital stay. Freedom of rein-
ervention was also lower in these patients compared with
hose more than three months old. At the last follow-up,
wo patients completed biventricular repair and one received
idirectional Glenn’s shunt.
ISCUSSION
espite the trend towards primary repair in the neonatal
eriod or early infancy in the management of complex
ongenital heart diseases, the modified BT shunt remains an
mportant first-stage palliation for many duct-dependent
yanotic lesions (5). However, in neonates this is associated
ith well-known morbidity such as diaphragmatic paralysis,
leural effusion, excessive pulmonary blood flow, and bron-
hopneumonia, leading to prolonged stay in the intensive
igure 5. Stent stenosis. (a) In-stent stenosis: layer of neointimal prolifera
uctus arising from left subclavian artery; (c) an additional stent was implare unit (1,2). In the subgroup of PAIVS patients who haveeverely hypoplastic RV and major sinusoids, modified BT
hunts may be associated with low cardiac output and death,
hought to be due to myocardial ischemia consequent to
educed diastolic pressure. In the series by Tamisier et al. (1)
f 62 infants below three months who underwent BT
hunts, there were 11 deaths among the neonates, of which
were patients with PAIVS or with univentricular heart.
Patent ductus arteriosus stenting seems a reasonable
lternative to a modified BT shunt, as it eliminates the acute
roblems associated with a thoracotomy, and the long-term
roblem of scarring, which may render definitive repair
ifficult. Animal studies data have shown that the stented
DA has a reasonably good short- and medium-term
atency, with neointimal proliferation being a limiting
actor (4,6). However, results of an early report involving a
mall number of patients were not very encouraging (3,4).
ajor complications such as perforations of RV wall and
ulmonary artery, dislodgement, or suboptimal position of
tent were encountered. Furthermore, stent implantation
as performed mainly through an axillary artery cutdown,
hich we felt was too invasive. It is perhaps for these
easons that PDA stenting remains marginal to modified
T shunt as a form of first-stage palliation. However, in
etween white arrows; (b) stenosis of unstented segment of a long vertical
over the stenosed and unstented segment of the ductus.tion b
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July 21, 2004:438–45 PDA Stenting in Duct-Dependent Cardiac Lesionsore recent reports the results were more encouraging (7,8).
n these two studies, the patients were mainly those with
ritical PS and PAIVS who had already received definitive
reatment in the form of balloon dilation with or without
F valvotomy, and PDA stenting was done transvenously as
n additional procedure. In our series these patients were
igure 6. Outcome of 51 patients who underwent successful stent implan-
ation. BT  Blalock-Taussig; LPA  left pulmonary artery; PA 
ulmonary artery; PDA  patent ductus arteriosus; RPA  right pulmo-
ary artery.
igure 7. Freedom from reintervention. The reintervention included
lalock-Taussig shunt surgery.xcluded, as our objective was to look at the feasibility,
omplications, and outcome of PDA stenting as a nonsur-
ical alternative for first-stage palliation in duct-dependent
ulmonary circulation. Furthermore, in PAIVS and critical
S patients in whom the right ventricular outflow obstruc-
ion is already opened with good forward flow, the stented
DA may rapidly thrombose off because of competitive
ow, rendering analysis of the entire cohort difficult. In the
chneider et al. series (7), the subgroup of patients where
DA stenting was truly a first-stage palliation, stent delivery
as via axillary artery cutdown or percutaneously via the
emoral artery using significantly large sheaths (5F to 6F).
ith today’s much improved coronary stent features such as
exibility, trackability, and heparin coating (9), aided by a
ariety of coronary guide wires and the use of 4F long
heathes via the femoral artery, we found that axillary
utdown can be avoided while preserving the femoral
rteries. This approach was also used by Gewillig et al. (8)
n two patients.
echnique. The PDA in cyanotic lesions, in particular
OF with pulmonary atresia, tend to have more proximal
rigin, have a curved tubular shape, and may sometimes take
tortuous course (10). This requires a cut pigtail catheter,
iving it an inverted J-shaped tip to enable engagement of
he PDA ampulla and guide wire navigation across the
DA, and finally to secure anchoring of the wire tip in a
istal pulmonary artery branch. Once the stiffer part of the
ire is across the PDA, it tends to render the ductus more
orizontal and straight in orientation, enabling stent im-
lantation with reasonable ease. In eight patients, all of
hem with TOF–pulmonary atresia, the PDA arose very
roximally such that guide-wire anchoring in a distal pul-
ter-related procedure (balloon dilation of stent and restenting) andcathe
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PDA Stenting in Duct-Dependent Cardiac Lesions July 21, 2004:438–45onary artery branch was not possible. In such patients,
tent delivery was done transvenously using 6F Judkin’s
ight or Left guiding catheter, which was passed through
he VSD and anterogradely into the ascending aorta
Fig. 4). This was considerably more difficult compared to
he retrograde technique.
In five patients the procedure was unsuccessful because
he ductus had a very tortuous course with multiple sharp,
cute angle bends, making it impossible to pass and anchor
he guide wire.
Another important issue is to ensure that the entire
ength of the PDA is stented. Unstented segments of the
DA have a propensity for constriction. This was observed
n two of our earlier patients who required additional stent
mplantation.
ranch pulmonary artery stenosis. It is not uncommon,
articularly in TOF–pulmonary atresia, for the ductal tissue
o cause branch pulmonary artery stenosis at its site of
nsertion (“pulmonary coarctation”) (11,12). Early in the
eries we proceeded with stent implantation when the
tenosis was mild (7 patients, all TOF–pulmonary atresia).
e found that branch pulmonary artery stenosis was accel-
rated with PDA stenting and the patients required a
odified BT shunt to salvage the stenotic branch pulmo-
ary artery. The stent may have provoked an intense
eointimal proliferation and fibrosis in the ductal tissues
ncircling the pulmonary artery wall. This condition has not
een adequately highlighted and we feel that it is an
bsolute contraindication for PDA stenting in hearts with
ingle ventricle destined for the Fontan track. It is therefore
andatory to angiographically evaluate the state of the
ulmonary arteries before stenting the PDA, and the
our-chamber view is useful in showing the pulmonary
ifurcation and presence of branch PA stenosis at the site of
uctal insertion.
tent durability. The durability of the coronary stents is
imited by thrombosis and neointimal proliferation (4,6,13).
he newer heparin-coated and drug-eluting stents are
esigned to overcome these two problems (14). In our
eries, there was a reduction in oxygen saturation on follow
p. In one patient (2.1%) the stent was blocked three weeks
ost implantation, probably due to thrombosis. Six patients
ad significant progression of the ductal flow restriction
equiring reintervention within six months. This progres-
ion is probably due to accelerated neointimal proliferation.
ur results were similar to those of Schneider et al. in that
ntimal proliferation leading to significant in-stent stenosis
ithin six months is common, necessitating redilations (7).
nferior stent durability compared to conventional surgical
hunt, among other factors, led Gibbs et al. (4) to conclude
hat PDA stenting cannot be recommended. However, with
dvances in pediatric cardiac surgery, a bidirectional Glenn
hunt and Rastelli-type operations may be safely performed
t four to six months (15–17); hence the inferior durability
f a stented PDA may no longer be a major issue. Alter-
atively, the idea of a drug-eluting stent is attractive, but theechanism of in-stent stenosis in PDA is different from
hat of atheromatous coronary artery, and therefore this
evelopment may not necessarily prolong stent patency (14).
onclusions. With improved features of coronary stents
nd delivery system, as well as the use of 4F long sheath,
aintaining ductal patency by percutaneous implantation of
stent offers a safe and feasible means of short-term
alliation in neonates and young infants. Patent ductus
rteriosus stenting, however, tends to worsen preexisting
ranch pulmonary artery stenosis at the site of PDA
nsertion, and its presence should perhaps be considered an
bsolute contraindication to PDA stenting in patients with
ingle-ventricle physiology. Although PDA stenting tends
o be less durable than conventional surgical shunt, this may
ot be a significant problem if definitive surgeries are
erformed at an earlier age and the restrictive duct can be
edilated and restented. Cognizant of its limitations, we feel
hat PDA stenting is a reasonable alternative to surgical
ystemic to pulmonary arterial shunts in securing pulmonary
lood flow in duct-dependent cyanotic heart disease and
eserves further evaluation.
cknowledgments
e greatly appreciate the help of Muhaneeza Hanafiah in
he preparation of the manuscript and Mohd Faizal Ramli
or his assistance in the statistical analysis.
eprint requests and correspondence: Dr. Mazeni Alwi,
epartment of Paediatric Cardiology, Institut Jantung Negara
National Heart Institute), 145, Jalan Tun Razak, 50400 Kuala
umpur, Malaysia. E-mail: mazeni@ijn.com.my.
EFERENCES
1. Tamisier D, Vouhe PR, Vermant F, Leca F, Massoat C, Neveux J.
Modified Blalock Taussig shunts: results in infants less than 3 months
of age. Ann Thorac Surg 1990;40:797–802.
2. Sivakumar K, Shivaprakasha K, Rao SG, Krisha Kumar R. Operative
outcome and intermediate term follow up of neonatal Blalock Taussig
shunts. Indian Heart J 2001;53:66–70.
3. Gibbs J, Rothman M, Rees M, Parsons J, Blackburn M, Ruiz C.
Stenting of the arterial duct: a new approach to palliation for
pulmonary atresia. Br Heart J 1992;67:240–5.
4. Gibbs JL, Uzun O, Blackburn MEC, Wren C, Hamilton L, Watter-
son KG. Fate of the stented arterial duct. Circulation 1999;99:2621–5.
5. Gold JP, Violaris R, Engle MA, et al. A five-year clinical experience
with 112 BT shunts. J Card Surg 1993;8:9–17.
6. Rosenthal E, Qureshi SA, Tabatabaie AH, et al. Medium-term results
of experimental stent implantation into the ductus arteriosus. Am
Heart J 1996;132:657–63.
7. Schneider M, Zartner P, Sidiropoulos A, Konertz W, Hausdorf G.
Stent implantation of the duct in newborns with duct-dependent
circulation. Eur Heart J 1998;19:1401–9.
8. Gewillig M, Boshoff DE, Dens J, Mertens L, Benson L. Stenting the
neonatal duct in duct dependent pulmonary circulation: new tech-
niques, better results. J Am Coll Cardiol 2004;43:107–12.
9. Rieu R, Barragan P, Garitey V, et al. Assessment the trackability,
flexibility and conformability of coronary stents: a comparative analy-
sis. Catheter Cardiovasc Interv 2003;59:496–503.
0. Abrams SE, Walsh KP. Arterial duct morphology with reference to
angioplasty and stenting. Int J Cardiol 1993;40:27–33.
1. Elzenga NJ, Gittenberger-De Groot AC. The ductus arteriosus and
stenoses of the pulmonary arteries in pulmonary atresia. Int J Cardiol
1986;11:195–208.
11
1
1
1
1
445JACC Vol. 44, No. 2, 2004 Alwi et al.
July 21, 2004:438–45 PDA Stenting in Duct-Dependent Cardiac Lesions2. Waldman JD, Karp RB, Gittenberger-De Groot AC, Agarwala B,
Glagov S. Spontaneous acquisition of discontinuous pulmonary arter-
ies. Ann Thorac Surg 1996;62:161–8.
3. Coe J, Olley P. A novel method to maintain ductus arteriosus patency.
J Am Coll Cardiol 1991;18:837–41.
4. Hiatt BL, Carter AJ, Yeung AC. The drug-eluting stent: is it the Holy
Grail? Rev Cardiovasc Med 2001;2:190–6.
5. Mohan Reddy V, Liddicoat JR, Hanley FL. Primary bidirectionalsuperior cavopulmonary shunt in infants between 1 and 4 months of
age. Ann Thorac Surg 1995;59:1120–6.
6. Chang AC, Hanley FL, Wernovsky G, et al. Early bidirectional
cavopulmonary shunt in young infants: postoperative course and early
results. Circulation 1993;88 Part 2:149–58.
7. Scott MB, Ralph SM, Hani AH, Dennis CC, Thomas JK, Edward
LB. Bidirectional superior cavopulmonary connection in young in-
fants. Circulation 1996;94 Suppl II:II5–11.
